Imovax Polio

Imovax Polio: Protect Your Family from Poliomyelitis

Imovax Polio is a clear and colorless suspension designed to prevent poliomyelitis, a severely disabling and deforming disease caused by poliovirus. This vaccine is indicated for primary and booster vaccinations in infants, children, and adults, starting from 2 months of age. It is prepared from poliovirus types 1, 2, and 3 cultured on Vero cells, purified, and inactivated by formaldehyde.

The vaccine is highly effective, with seroprotection rates of 99% to 100% for types 1 and 3 polioviruses, and 97% to 100% for type 2 poliovirus, one month after the primary vaccination series. A booster dose leads to a significant increase in antibody titers, with seroprotection rates of 97.5% to 100% for all three types of polioviruses.

Imovax Polio is part of the routine vaccination schedule recommended by health authorities. It induces the production of neutralizing antibodies against each type of virus, which are crucial for protective efficacy. The vaccine reduces fecal and pharyngeal excretion of poliovirus, contributing to herd immunity in immunized populations.

For optimal protection, it is essential to follow the recommended vaccination schedule. This includes a primary series of three doses, with the first dose typically given at 6 or 8 weeks of age. A booster dose is recommended six months after the third dose for infants vaccinated at 6 weeks. Children in countries with a high risk of poliovirus reintroduction may receive additional doses as needed.

By choosing Imovax Polio, you are ensuring your family’s protection against this potentially devastating disease. This vaccine is manufactured by Sanofi Pasteur and is distributed by Sanofi Pasteur Limited. It is a sterile suspension of inactivated poliovirus types 1, 2, and 3, making it safe for use in individuals of all ages.